Doctors found to lack trust in drug company studies, by LA TimesQuicklink submitted by Ethan Hollow Permalink
Become a Fan
|Doctors are less likely to trust research studies performed with funding from corporate interests such as pharmaceutical companies, according to a new study. The report, published this week in the New England Journal of Medicine, reveals a long-suspected bias against such research among physicians. It also demonstrates the price companies have paid for public violations of trust, including examples of data manipulation and misrepresentation of study results.
In the study, researchers from Harvard Medical School asked physicians to read abstracts from studies reporting promising clinical data about a couple of different new drugs.
The time limit for entering new comments on this Quicklink has expired.
This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.